Effects of Insulin Resistance in Non-diabetic Acute Coronary Syndrome Patients

Not Applicable

Recruiting

• Conditions: Insulin Resistance
• Interventions: Procedure: Insulin resistance

• Registration Number: NCT06163768
• Lead Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City

Brief Summary

Effects of insulin resistance in non-diabetic acute coronary syndrome patients by the homeostasis model assessment index (HOMA2-IR)

Detailed Description

Help patients know about insulin resistance. If this condition persists for a long time, it will reduce the ability to produce insulin, thereby leading to increased blood sugar levels, causing type 2 diabetes. Helping doctors have a more general view, in order to come up with a strategy more effective monitoring and treatment, preventing diabetes and cardiovascular events.

Study Timeline

• Study First Submitted: 2023-11-15
• Status Verified: 2023-12
• Study First Submitted QC: 2023-12-01
• Last Update Submitted: 2023-12-01
• Study First Posted: 2023-12-11
• Last Update Posted: 2023-12-11
• Study Start: 2023-12-31
• Primary Completion: 2026-10-31
• Study Completion: 2026-12-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1

Inclusion Criteria

• Control group The researcher collected samples from healthy people over 18 years old who came for a health check and were concluded to have good health at the Health Examination Department of University of Medicine and Pharmacy Hospital, Ho Chi Minh City. Not falling within the exclusion criteria and agreeing to participate in the study were included in the study.
• Researchers -All patients diagnosed with Acute coronary syndrome who were over 18 years old, met the inclusion criteria and did not have exclusion criteria, and agreed to participate in the study were included in the study.

Exclusion Criteria

• Control group

  • Patients < 18 years old.
  • History of heart disease or stroke
  • Exclude diabetic subjects
  • Exclude subjects at high risk of insulin resistance

• Researchers

  • Have diabetes or have previously been diagnosed with diabetes.
  • Patients < 18 years old.
  • The patient does not participate in follow-up examinations and does not follow up treatment at the medical facility.
  • The patient died before reaching the hospital.
  • Patients with severe medical diseases: cirrhosis, cancer, obstructive pulmonary disease chronic obstructive pulmonary disease, chronic heart failure, severe kidney failure.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
insulin	Insulin resistance	This is a prospective study, without intervention in the clinical treatment plan at the hospital

Primary Outcome Measures

Name	Time	Method
Model HOMA-IR	January 2026	Use SPSS software to analyze data

Trial Locations

Locations (1)

Medical and Pharmaceutical University Hospital; 🇻🇳 Ho Chi Minh City, Five, Vietnam